Abstract:A comprehensive investigation of the Hg 2+ coordination chemistry and 197m/g Hg radiolabeling capabilities of cyclen-based commercial chelators, namely, DOTA and DOTAM (aka TCMC), along with their bifunctional counterparts, p -SCN-Bn-DOTA and p -SCN-Bn-TCMC, was conducted to assess the suitability of these frameworks as bifunctional chelators for the 197m/g Hg 2+ theranostic pair. Radiolabeling studies revealed that TCMC and DOTA exhibited low radiochemical yields (0%–6%), even when subjected to harsh conditions (80°C) and high ligand concentrations (10 –4 M). In contrast, p -SCN-Bn-TCMC and p -SCN-Bn-DOTA demonstrated significantly higher 197m/g Hg radiochemical yields (100% ± 0.0% and 70.9% ± 1.1%, respectively) under the same conditions. The [ 197 m/g Hg]Hg- p -SCN-Bn-TCMC complex was kinetically inert when challenged against human serum and glutathione. To understand the differences in labeling between the commercial chelators and their bifunctional counterparts, non-radioactive nat Hg 2+ complexes were assessed using NMR spectroscopy and DFT calculations. The NMR spectra of Hg-TCMC and Hg- p -SCN-Bn-TCMC suggested binding of the Hg 2+ ion through the cyclen backbone framework. DFT studies indicated that binding of the Hg 2+ ion within the backbone forms a thermodynamically stable product. However, competition can form between isothiocyanate binding and binding through the macrocycle, which was experimentally observed. The isothiocyanate bound coordination product was dominant at the radiochemical scale as, in comparison, the macrocycle bound product was seen at the NMR scale, agreeing with the DFT result. Furthermore, a bioconjugate of TCMC (TCMC-PSMA) targeting prostate-specific membrane antigen was synthesized and radiolabeled, resulting in an apparent molar activity of 0.089 MBq/nmol. However, the complex demonstrated significant degradation over 24 h when exposed to human serum and glutathione. Subsequently, cell binding assays were conducted, revealing a K i value ranging from 19.0 to 19.6 nM. This research provides crucial insight into the effectiveness of current commercial chelators in the context of 197m/g Hg 2+ radiolabeling. It underscores the necessity for the development of specific and customized chelators to these unique "soft" radiometals to advance 197m/g Hg 2+ radiopharmaceuticals.

Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn 2+ , Cu 2+ , Zn 2+ , Ga 3+ , In 3+ , Tb 3+ , and Lu 3

Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticals

Ln(III) Chelates-Functionalized Carbon Quantum Dots: Synthesis, Optical Studies and Multimodal Bioimaging Applications.

Investigation of Ln3+ complexation by a DOTA derivative substituted by an imidazothiadiazole: synthesis, solution structure, luminescence and relaxation properties

[ 186 Re]Re- and [ 99m Tc]Tc-Tricarbonyl Metal Complexes with 1,4,7-Triazacyclononane-Based Chelators Bearing Amide, Alcohol, or Ketone Pendent Groups

Origin of the Isomer Stability of Polymethylated DOTA Chelates Complexed with Ln3+ ions

Using Chiral Auxiliaries to Mimic the Effect of Chiral Media on the Structure of Lanthanide(III) Complexes Common in Bioimaging and Diagnostic MRI

Physicochemical properties of the high-field MRI-relevant [Gd(DTTA-Me)(H2O)2]- complex

Is Smaller Better? Cu2+/Cu+ Coordination Chemistry and Copper-64 Radiochemical Investigation of a 1,4,7-Triazacyclononane-Based Sulfur-Rich Chelator

Chelator-free synthesis of a dual-modality PET/MRI agent

Evaluation of Structurally Related Acyclic Ligands OBETA, EHDTA, and EGTA for Stable Mn2+ Complex Formation

Development of Thiacrown Ligands for Encapsulation of Mercury-197m/g into Radiopharmaceuticals

Complexation of 3p- C-NETA with radiometal ions: A density functional theory study for targeted radioimmunotherapy

Using Chiral Auxiliaries to Mimic the Effect of Chiral Media on the Structure of Lanthanide(III) Complexes Common in Bioimaging and Diagnostic MRI

Synthesis, Luminescence and Relaxometric Properties of Macrocyclic Lanthanide Complexes Appended with an Imidazothiadiazole, a Heterocyclic Bioactive Scaffold

Novel Chelating Agents for Zirconium-89-Positron Emission Tomography (PET) Imaging: Synthesis, DFT Calculation, Radiolabeling, and In Vitro and In Vivo Complex Stability

Decoration of 1,4,7,10‐tetraazacyclododecane‐1,4,7,10‐tetraacetic acid (DOTA) with N‐oxides increases the T1 relaxivity of Gd‐complexes

Chelation in One Fell Swoop: Optimizing Ligands for Smaller Radiometal Ions

Spectroscopic Study on the Complexation of trivalent Actinide and Lanthanide ions with TEDGA in Solution